CVY - Invesco Zacks Multi-Asset Income ETF

NYSEArca - Nasdaq Real Time Price. Currency in USD
21.62
-0.08 (-0.37%)
At close: 3:50PM EDT
Stock chart is not supported by your current browser
Previous Close21.70
Open21.65
Bid0.00 x 2200
Ask0.00 x 3100
Day's Range21.62 - 21.75
52 Week Range18.27 - 22.84
Volume13,765
Avg. Volume25,729
Net Assets230.33M
NAV21.89
PE Ratio (TTM)N/A
Yield3.64%
YTD Return14.69%
Beta (3Y Monthly)1.62
Expense Ratio (net)0.88%
Inception Date2006-09-21
Trade prices are not sourced from all markets
  • How GlaxoSmithKline Stock Has Performed in September
    Market Realist8 months ago

    How GlaxoSmithKline Stock Has Performed in September

    GlaxoSmithKline (GSK), a global pharmaceutical company, is focused on creating a sustainable growth model through expanding its business beyond pharmaceuticals. GlaxoSmithKline reports its financial statements in sterling pounds. GlaxoSmithKline ADR fell marginally by ~0.1% as compared to its previous close to the closing price of $40.51 on September 27.

  • TheStreet.com10 months ago

    11 Top High-Dividend-Yield ETFs for Income Investors

    Instead of investing in individual stocks, which carry high risk if a stock's share price falls, ETF investors have reduced risk exposure through diversification. Plus, ETFs have much lower fees, which translate to higher total returns over extended periods. Here are 11 top dividend ETFs that offer high dividend yields.

  • We're sorry this is all we were able to find about this topic.